XML 60 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information (Tables)
3 Months Ended
Mar. 30, 2014
Segment Results

The following tables present the Company’s segment results for the three months ended March 30, 2014 and March 31, 2013:

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 30, 2014

 

 

March 31, 2013

 

 

(Dollars in thousands)

 

Revenue

 

 

 

 

 

 

 

Vascular North America

$

62,506

 

 

$

56,674

 

Anesthesia/Respiratory North America

 

54,714

 

 

 

58,174

 

Surgical North America

 

35,231

 

 

 

36,688

 

EMEA

 

150,245

 

 

 

142,418

 

Asia

 

49,602

 

 

 

42,368

 

OEM

 

33,182

 

 

 

31,338

 

All other

 

53,066

 

 

 

44,217

 

Consolidated net revenues

$

438,546

 

 

$

411,877

 

 

 

Three Months Ended

 

 

March 30, 2014

 

 

March 31, 2013

 

 

(Dollars in thousands)

 

Operating Profit

 

 

 

 

 

 

 

Vascular North America

$

9,392

 

 

$

5,026

 

Anesthesia/Respiratory North America

 

5,687

 

 

 

5,678

 

Surgical North America

 

10,548

 

 

 

13,662

 

EMEA

 

26,881

 

 

 

23,242

 

Asia

 

12,837

 

 

 

12,096

 

OEM

 

6,604

 

 

 

6,360

 

All other

 

9,768

 

 

 

2,015

 

Total segment operating profit (1)

 

81,717

 

 

 

68,079

 

Unallocated expenses (2)

 

(22,697

)

 

 

(18,675

)

Income from continuing operations before

   Interest and taxes

$

59,020

 

 

$

49,404

 

 

(1)

Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses.

(2)

Unallocated expenses primarily include manufacturing variances with the exception of fixed manufacturing cost absorption variances and restructuring and other impairment charges.

 

 

Three Months Ended

 

 

March 30, 2014

 

 

March 31, 2013

 

 

(Dollars in thousands)

 

Depreciation and Amortization

 

 

 

 

 

 

 

Vascular North America

$

7,855

 

 

$

6,559

 

Anesthesia/Respiratory North America

 

4,428

 

 

 

3,841

 

Surgical North America

 

2,369

 

 

 

2,554

 

EMEA

 

8,937

 

 

 

7,151

 

Asia

 

1,838

 

 

 

1,212

 

OEM

 

1,456

 

 

 

1,148

 

All other

 

4,530

 

 

 

3,876

 

Consolidated depreciation and amortization

$

31,413

 

 

$

26,341

 

 

Total Net Revenues and Total Net Property, Plant and Equipment by Geographic Region

The following table provides total net revenues for the three months ended March 30, 2014 and March 31, 2013 and total net property, plant and equipment by geographic region as of March 30, 2014 and December 31, 2013:

 

 

Three Months Ended

 

 

March 30, 2014

 

 

March 31, 2013

 

 

(Dollars in thousands)

 

Net revenue (based on business unit location)

 

 

 

 

 

 

 

United States

$

216,461

 

 

$

207,514

 

Other Americas

 

14,771

 

 

 

14,151

 

Germany

 

33,991

 

 

 

33,751

 

Other Europe

 

134,784

 

 

 

106,686

 

All other

 

38,539

 

 

 

49,775

 

 

$

438,546

 

 

$

411,877

 

 

 

March 30, 2014

 

 

December 31, 2013

 

 

(Dollars in thousands)

 

Net property, plant and equipment

 

 

 

 

 

 

 

United States

$

203,005

 

 

$

203,985

 

Other Americas

 

11,933

 

 

 

12,350

 

Germany

 

12,191

 

 

 

12,135

 

Other Europe

 

63,991

 

 

 

61,891

 

All other

 

37,559

 

 

 

35,539

 

 

$

328,679

 

 

$

325,900